Related Experiment Videos
[Immunomodulating properties of leukinferon]
Sovetskaia Meditsina
|January 1, 1990
Summary
Leukinferon injections were generally well-tolerated in healthy volunteers, despite some temporary side effects. The drug demonstrated immunomodulating properties by activating the interferon system, particularly IRL-gamma.
Area of Science:
- Immunology
- Pharmacology
Background:
- Leukinferon is an immunomodulatory drug.
- Understanding its tolerance and effects is crucial for therapeutic applications.
Purpose of the Study:
- To evaluate the tolerance and immunomodulating properties of leukinferon for injections.
- To assess the safety and efficacy of leukinferon in healthy volunteers.
Main Methods:
- 13 healthy volunteers received leukinferon via inhalation and intramuscularly.
- Dosage: 10,000 MU twice daily for 3 days.
- Monitoring for side effects, systemic disorders, and immune system activation.
Main Results:
- Intramuscular administration caused transient side effects (pyrogenicity, weakness, headache).
- The drug was satisfactorily tolerated overall, with no detected visceral or allergic reactions.
- T-lymphocytes were most sensitive; leukinferon activated the interferon system, especially IRL-gamma.
Conclusions:
- Leukinferon exhibits tolerance and immunomodulating effects.
- Activation of the interferon system, particularly IRL-gamma, is a key finding.
- Further research may explore its therapeutic potential based on these properties.